Clearstead Trust’s Accendra Health ACH Stock Holding History

Clearstead Trust’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-48	Closed	-$231	–	1367
2025 Q3	$231	Hold	48	–	–	﹤0.01%	1485
2025 Q2	$437	Buy	+48	New	+$354	﹤0.01%	1356

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Clearstead Trust's ACH Position: Q4 2025 in Review

Clearstead Trust sold out of Accendra Health (ACH) in Q4 2025, closing a stake of 48 shares — an estimated $231 sold.

Clearstead Trust first reported a position in ACH in Q2 2025 and held it in 2 quarters. The position peaked at $437 in Q2 2025. 168 funds tracked by Wall St. Rank hold ACH as of Q4 2025.

Clearstead Trust reported no remaining Accendra Health position as of Q4 2025 after selling out during the quarter.
Clearstead Trust sold 48 Accendra Health shares in Q4 2025, an estimated $231.
Clearstead Trust first reported a position in Accendra Health in Q2 2025 and held it in 2 quarters.
Clearstead Trust's Accendra Health position peaked at $437 in Q2 2025.
168 funds tracked by Wall St. Rank held Accendra Health as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.